AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
142 hedge funds and large institutions have $727M invested in Aerie Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
52% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 31
Holders
142
Holding in Top 10
1
Calls
$281K
Puts
$337K
Top Buyers
| 1 | +$8.78M | |
| 2 | +$6.99M | |
| 3 | +$6.05M | |
| 4 |
DM
Deerfield Management
New York
|
+$5.31M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$3.66M |
Top Sellers
| 1 | -$27.8M | |
| 2 | -$8.59M | |
| 3 | -$7.48M | |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$3.73M |
| 5 |
BlackRock
New York
|
-$3.71M |